T. Tajima et al., A novel missense mutation of mineralocorticoid receptor gene in one Japanese family with a renal form of pseudohypoaldosteronism type 1, J CLIN END, 85(12), 2000, pp. 4690-4694
Pseudohypoaldosteronism type 1 (PHA1) is a rare condition characterized by
neonatal salt loss with dehydration, hypotension, hyperkalemia, and metabol
ic acidosis, despite elevated plasma aldosterone levels and PRA. Two modes
of inheritance of PHA1 have been described: an autosomal dominant form and
an autosomal recessive form. An autosomal recessive form manifests severe l
ife-long salt wasting resulting from multiple mineralocorticoid target tiss
ue such as sweat, salivary glands, the colonic epithelium, and lung. Contra
ry, an autosomal dominant PHA1 manifests milder salt wasting that gradually
improves with advancing age. Recently, in one sporadic and four dominant c
ases, four different mutations including two frame shift mutations, two pre
mature termination codons, and one splice site mutation in the mineralocort
icoid receptor (R-TR) gene were identified.
We studied the molecular mechanisms of one Japanese family with a renal for
m of PRA1. FCR and direct sequencing of the MR gene identified a heterozygo
us point mutation changing codon 924 Leu (CTG) to CCC(Pro) (L924P) in all a
ffected members. COS-1 cells were transfected with expression vectors for e
ither wild type or the mutant MR-L924P receptors, together with the reporte
r plasmid (glucocorticoid response element tk-CAT). Aldosterone increased C
AT activity in cells expressing wild-type receptor, but had no effect in ce
lls expressing the mutant receptors. These results suggest that mineralocor
ticoid resistance in this family is due to a missense mutation in the MR ge
ne. To our knowledge, this is the first case of the missense mutation of th
e MR gene in renal PHA1.